M JOYCE K SASSE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health OMAHA, NE NPI 1972619062

General Payments — all program years on this page

$5,810.51

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 39
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $4,577.26 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Honoraria $1,925.001
Travel and Lodging $1,428.973
Food and Beverage $1,223.2913

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Supernus Pharmaceuticals, Inc. $3,706.609
E.R. Squibb & Sons, L.L.C. $258.953
ABBVIE INC. $249.662
Neurocrine BioSciences, Inc. $124.901
HARMONY BIOSCIENCES LLC $120.441
Alkermes, Inc. $116.711

By program year

Program yearAmountRecords
2021 $72.855
2022 $307.767
2023 $852.6410
2024 $4,577.2617

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1101500909 E.R. Squibb & Sons, L.L.C. $125.00 09/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101500923 E.R. Squibb & Sons, L.L.C. $11.94 11/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1101500973 E.R. Squibb & Sons, L.L.C. $122.01 12/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108146643 ABBVIE INC. $124.83 04/04/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1108146645 ABBVIE INC. $124.83 05/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120591744 Alkermes, Inc. $116.71 09/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1126079729 HARMONY BIOSCIENCES LLC $120.44 04/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147816230 Supernus Pharmaceuticals, Inc. $462.40 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147816232 Supernus Pharmaceuticals, Inc. $685.20 06/13/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1147816234 Supernus Pharmaceuticals, Inc. $1,925.00 06/13/2024 Honoraria Undisputed 01/23/2026 View at CMS
1147896739 Supernus Pharmaceuticals, Inc. $27.14 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896741 Supernus Pharmaceuticals, Inc. $42.19 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896743 Supernus Pharmaceuticals, Inc. $63.39 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896745 Supernus Pharmaceuticals, Inc. $75.25 06/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896747 Supernus Pharmaceuticals, Inc. $144.66 06/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147896749 Supernus Pharmaceuticals, Inc. $281.37 06/14/2024 Travel and Lodging Undisputed 01/23/2026 View at CMS
1150921367 Neurocrine Biosciences, Inc. $124.90 04/03/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.